Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the First-in-Class GLP-1 and Amylin Receptor Agonist, Amycretin: A First-in-Human, Phase 1, Double-Blind, Randomised, Placebo-Controlled Trial
Wexler DJ, Mayberry LS, Nelson LA, Lema-Driscoll J, Flores LC, Malloy M, et al
Myopathy , by which we refer to any muscular sign or symptom, are common in lcFAOD patients
doi: 10.1016/S0140-6736(23)00001-6 2 Collaborators GBDD
Cranberry : natural mineral water, acidity regulator citric acid, L-carnitine 0.2%, flavouring, sweeteners sodium cyclamate, acesulfame K, aspartame (contains a source of phenylalanine ), sodium saccharin, colour ammonia - sulphite caramel and Azorubin*, preservative potassium sorbate, sodium benzoate
Oxalate flux across the intestine: contributions from membrane transporters